empagliflozin 10 MG / linagliptin 5 MG [Glyxambi]
RxNorm concept 1602111, branded drug component (sbdc).
- RxCUI
- 1602111
- Term type
- Branded drug component (SBDC)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1602111 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Related concepts
- empagliflozin 10 MG / linagliptin 5 MG Oral Tablet [Glyxambi] (SBD, constitutes)
- Glyxambi (BN, has ingredient)
- linagliptin 5 MG (SCDC, tradename of)
- empagliflozin 10 MG (SCDC, tradename of)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 1602111 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1602111 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1602111. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.